| Category | Barrier Repair |
| Founded | 2005 |
| Headquarters | New York, USA |
| Listing | Not separately listed; parent L'Oréal is listed on Euronext Paris (OR.PA) |
| Latest revenue | Group FY2025 sales EUR 44.05bn, operating profit EUR 8.89bn |
| Hero SKUs | Foaming Facial Cleanser |
Brand History
CeraVe was founded in the United States in 2005 with dermatologist input, built around ceramides, hyaluronic acid and niacinamide for barrier repair, sold in minimal, pharmacy-style packaging through hospitals and drugstores. In 2017 L'Oréal bought the brand from Valeant for about USD 1.3bn and folded it into what is now the Dermatological Beauty division, using group distribution to take it mass-market.
In China the brand rode two shifts: growing ingredient literacy around ceramides, and consumers moving from whitening and acne toward barrier repair. A simple duo — foaming cleanser plus moisturising lotion — opened the market at around RMB 100, later extended into SA cleansers and overnight repair. Dermatological Beauty was 16% of L'Oréal sales in 2025 at a 26.1% operating margin, the group's most profitable division, with China named among its main growth sources.
Hero Products
Three-Year Financials
| Year | Revenue (EUR bn) | YoY | Net profit (EUR bn) |
|---|---|---|---|
| 2023 | 41.18 | +7.6% | 6.18 |
| 2024 | 43.49 | +5.6% | 6.41 |
| 2025 | 44.05 | +1.3% | 6.13 |
Brand-level：L'Oréal does not disclose brand-level revenue. Dermatological Beauty, which houses CeraVe, was 16% of group sales in 2025 with a 26.1% operating margin — the highest of the four divisions — and the group reports double-digit growth for the division in China.
Source：L'Oréal 2025 annual report and consolidated statements; 2017 acquisition announcement
Company Coverage
- 2026-02Dermatological Beauty margin at 26.1%
L'Oréal's 2025 annual report shows the division at 16% of sales with the highest operating margin of the four.
Source：L'Oréal 2025 annual report - 2025-12Group doubles down on dermo-beauty
L'Oréal raised its stake in Galderma and took over Kering Beauté, deepening its bet on dermatological beauty.
Source：L'Oréal release - 2025-09Double-digit growth in China
The group has repeatedly named China among the main growth markets for Dermatological Beauty.
Source：Group filings
Editor's note: CeraVe is L'Oréal's most successful attempt to mass-market dermo-cosmetics in China — turning a hospital-channel barrier concept into a two-SKU routine at around RMB 100. Its moat is not a formula secret but the fact that it taught consumers to say 'ceramide' themselves. The risk is that domestic brands are now copying the same story at a lower cost.